Cargando…

Biochemical effects of irbesartan in experimental diabetic nephropathy

BACKGROUND: Diabetic nephropathy (DN) is one of the most common causes of end-stage renal failure. The pathogenesis of progressive renal damage is multifactorial and the mechanism by which hyperglycemia causes microangiopathy in diabetic glomeruli is still poorly understood. Because the renin angiot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaishya, Richa, Singh, J., Lal, Harbans
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846497/ https://www.ncbi.nlm.nih.gov/pubmed/20407554 http://dx.doi.org/10.4103/0253-7613.59922

Ejemplares similares

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Authors’ reply
por: Vaishya, Richa, et al.
Publicado: (2010)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
por: Broedbaek, Kasper, et al.
Publicado: (2011)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
por: Chen, Xiao-Wen, et al.
Publicado: (2016)

Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
por: Puri, Vivek, et al.
Publicado: (2020)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
por: Persson, Frederik, et al.
Publicado: (2009)

Irbesartan improves arterial compliance more than lisinopril
por: Ali, Khalid, et al.
Publicado: (2009)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

The effect of solution environment and the electrostatic factor on the crystallisation of desmotropes of irbesartan
por: Araya-Sibaja, Andrea M., et al.
Publicado: (2019)

Late-Onset Rash from Irbesartan: An Immunological Reaction
por: Cardoso, Bárbara Kong, et al.
Publicado: (2019)

AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress
por: Boccellino, Mariarosaria, et al.
Publicado: (2018)

Influence of AGTR1 and ABCB1 Gene Polymorphism on the Curative Effect of Irbesartan
por: Wang, Qiao, et al.
Publicado: (2022)

Effects of irbesartan on myocardial injury in diabetic rats: The role of NLRP3/ASC/Caspase-1 pathway
por: Rong, Li, et al.
Publicado: (2020)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
por: Jones, M. R., et al.
Publicado: (2016)

The antihypertensive effect of irbesartan in spontaneously hypertensive rats is associated with improvement of the leptin–adiponectin imbalance
por: Weng, Junting, et al.
Publicado: (2021)

Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2014)

Irbesartan Induced Cutaneous Melanoma! Second Case in the Medical Literature!
por: Tchernev, Georgi, et al.
Publicado: (2019)

A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Effects of Irbesartan Pretreatment on Pancreatic β-Cell Apoptosis in STZ-Induced Acute Prediabetic Mice
por: Chen, Cuihong, et al.
Publicado: (2018)

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease
por: Li, Tao, et al.
Publicado: (2018)

Effects of irbesartan on phenotypic alterations in monocytes and the inflammatory status of hypertensive patients with left ventricular hypertrophy
por: Zhang, Jingsi, et al.
Publicado: (2021)

Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
por: Burnier, Michel, et al.
Publicado: (2005)

Elisa in the serodiagnosis of active tuberculosis
por: Parkash, Chugh, et al.
Publicado: (1994)

Irbesartan desmotropes: Solid-state characterization, thermodynamic study and dissolution properties
por: Araya-Sibaja, Andrea Mariela, et al.
Publicado: (2019)

Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan
por: Patel, Jaydeep, et al.
Publicado: (2011)

Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
por: Park, Chang Gyu, et al.
Publicado: (2006)

Effects of Ang II Receptor Blocker Irbesartan on Adipose Tissue Function in Mice with Metabolic Disorders
por: Maeda, Akinobu, et al.
Publicado: (2014)

Effects of Irbesartan and Amlodipine Besylate Tablets on the Intestinal Microflora of Rats With Hypertensive Renal Damage
por: Yu, Jing, et al.
Publicado: (2022)

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension
por: Onishi, Akira, et al.
Publicado: (2013)

Renoprotective effect of irbesartan in a rat model of gentamicin-induced nephrotoxicity: Role of oxidative stress
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019)

Pharmacokinetic study on the interaction between succinic acid and irbesartan in rats and its potential mechanism
por: Wang, Yongpeng, et al.
Publicado: (2021)

Effect of Prunetin on Streptozotocin-Induced Diabetic Nephropathy in Rats - a Biochemical and Molecular Approach
por: Samy, Jose Vinoth Raja Antony, et al.
Publicado: (2023)

Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy
por: Nagai, Noriaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_95an9c387mj7nh4hmoo9v1fg9p